TY  - GEN
AU  - Ayala, Rosa
AU  - Fernández, Rafael Alonso
AU  - García-Gutiérrez, Valentín
AU  - Alvarez-Larrán, Alberto
AU  - Osorio, Santiago
AU  - Sánchez-Pina, Jose M
AU  - Carreño-Tarragona, Gonzalo
AU  - Álvarez, Noemi
AU  - Gómez-Casares, María Teresa
AU  - Duran, Antonia
AU  - Gorrochategi, Julian
AU  - Hernández-Boluda, Juan Carlos
AU  - Martinez-Lopez, Joaquin
PY  - 2023
DO  - 10.1002/jha2.685
UR  - https://hdl.handle.net/20.500.12105/23116
AB  - This phase Ib, non-randomized, open-label study evaluates the safety and tolerability of ruxolitinib in combination with nilotinib and prednisone in patients with naïve or ruxolitinib-resistant myelofibrosis (MF). A total of 15 patients with primary...
LA  - eng
PB  - Wiley
TI  - Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study
TY  - research article
ER  -